Overview

A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study

Status:
NOT_YET_RECRUITING

Trial end date:
2025-11-01

Target enrollment:

Participant gender:

Summary

To Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults after taking the drugs with food (fed state).

Phase:

PHASE1

Details

Lead Sponsor:

AJU Pharm Co., Ltd.

Treatments:

Drug Evaluation